Lung Cancer

In this video, Lillian L. Siu, MD, FRCPC, discusses two keynote presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

In this video, Julie A. Barta, MD, pulmonologist and assistant professor at Thomas Jefferson University Hospitals, discusses presentations on lung cancer from CHEST 2021.

More than 80% of therapies tested in phase 3 oncology trials did not demonstrate clinically meaningful benefit in extending survival, according to results of a study published in JNCCN — Journal of the National Comprehensive Cancer Network.

Nearly a quarter of patients with heavily pretreated non-small cell lung cancer achieved an objective response to an infusion of LN-145, according to study results presented at Society for the Immunotherapy of Cancer Annual Meeting.

Lung Cancer Awareness Month, observed every November, is intended to educate the public about the potential causes and risk factors of the disease.

In this video, Julie A. Barta, MD, pulmonologist and assistant professor at Thomas Jefferson University Hospitals, talks with Healio about a discussion on controversial new lung cancer screening guidance presented at CHEST.

Julie A. Barta, MD, pulmonologist and assistant professor at Thomas Jefferson University Hospitals, spoke with Healio about a presentation on lung cancer in women from CHEST 2021.

Peter J. Mazzone, MD, MPH, pulmonologist and director of the lung cancer program for the Respiratory Institute at Cleveland Clinic, discussed takeaways for oncologists from the CHEST annual meeting.

The FDA granted fast track designation to bemcentinib for treatment of certain patients with non-small cell lung cancer.

The addition of nivolumab to neoadjuvant chemotherapy significantly improved EFS among patients with resectable non-small cell lung cancer, according to topline data released by the agent’s manufacturer.